Allogeneic transplantation (allohct) in acute myeloid leukemia (AML) with flt3 mutations: Study of outcome at the era of targeted therapy

Loutsidi, NE; Dimitraki, EK; Tsonis, I; Karaolidou, F; Roumelioti, A; Apsemidou, A; Gardeli, D; Dellatola, M; Babali, V; Kaouranis, K; Ligdi, L; Christoforou, P; Garofalaki, M; Tziotziou, I; Mellios, Z; Giatra, C; Tzenou, T; Tzannou, I; Bouzani, M; Delimbasi, S; Pagoni, M; Baltadakis, I; Gigantes, S; Karakasis, D

BONE MARROW TRANSPLANTATION, 2022; 57 (SUPPL 1): 239